MY UROLOGIST GOT ALL ABOVE RESULTS FROM MY PRE-SURGERY STAGING IMAGING. HE SAID THAT ALL WAS OK FOR PROCEEDING WITH...
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Your Urologist's Decision — What "All OK" Means
Thank you for clarifying this. Your urologist's decision to proceed with RARP (Robot-Assisted Radical Prostatectomy) based on your staging imaging makes complete sense. Let me explain the clinical reasoning.
Why Your Urologist Said "All OK for RARP"
Your staging imaging showed exactly what your urologist needed to see before recommending surgery:
The Green Lights for Surgery:
✅ No bone metastasis — bone scan showed no cancer spread to skeleton
✅ No lymph node involvement — CT showed normal pelvic lymph nodes
✅ No distant metastasis — abdomen/pelvis imaging clear
✅ Cancer appears localized — confined to prostate gland
✅ No contraindications to surgery — no findings that would make surgery unsafe
In clinical terms: Your staging workup confirmed M0 N0 disease (no metastasis, no node involvement), which means surgery has a realistic chance of curing your cancer by completely removing it.
Why RARP Was the Right Choice for YOU
According to NCCN Prostate Cancer Guidelines, for intermediate-risk patients like you with:
- Gleason 7 (3+4)
- PSA 5.14 ng/mL
- No evidence of spread
- Age 71 with good health status
Radical prostatectomy is a standard curative-intent treatment option because:
- Complete removal — surgery removes the entire prostate and cancer in one procedure
- Pathological staging — the removed prostate is examined to confirm cancer extent (more accurate than imaging)
- Curative potential — if all cancer is removed and PSA becomes undetectable, you may be cured
- No ongoing treatment — unlike radiation, which requires multiple sessions
RARP specifically (robot-assisted) offers advantages:
- Smaller incisions than open surgery
- Better visualization with magnification
- Potentially faster recovery
- Comparable cancer control to open surgery
What "All OK" Meant in Practice
Your urologist essentially confirmed:
| Staging Finding | What It Means | Surgical Implication | |---|---|---| | Normal bone scan | Cancer hasn't spread to bones | Surgery can be curative | | Normal pelvic nodes | No lymph node metastasis | No need for extended lymph node dissection | | Normal CT abdomen/pelvis | No distant spread | Cancer is localized | | Prostate heterogeneity only | Cancer confined to gland | Surgical margins likely achievable |
Translation: "Your cancer is exactly where we think it is (in the prostate), it hasn't spread anywhere else, and we can remove it surgically with curative intent."
The Clinical Decision-Making Process
Your urologist followed the standard staging protocol for intermediate-risk prostate cancer:
Step 1: Biopsy confirmed Gleason 7 cancer ✓ (March 2025)
Step 2: Staging imaging ruled out spread ✓ (April 2025)
- Bone scan: negative
- CT abdomen/pelvis: negative
Step 3: Risk stratification confirmed intermediate-risk ✓
- PSA 5.14
- Gleason 7
- Clinical stage T1c
Step 4: Treatment options discussed ✓
- Active surveillance (not ideal for Gleason 7)
- Radiation therapy (alternative option)
- Radical prostatectomy (recommended) ← Your choice
Step 5: Pre-operative clearance ✓
- Imaging shows no contraindications
- "All OK for RARP"
What Happened Next
Based on your medical timeline, you had your RARP on [date removed] — just 27 days after your staging imaging. This quick turnaround is typical when:
- Staging imaging is clear
- Patient is medically fit
- Surgical schedule allows
Why This Matters for Your Recovery & Follow-Up
Because your pre-surgery staging showed localized disease with no spread, your post-surgery expectations are:
✅ Curative intent surgery — goal was complete cancer removal
✅ PSA should become undetectable — if surgery successful
✅ Regular PSA monitoring — to detect any recurrence early
✅ No immediate adjuvant therapy needed — unless pathology shows high-risk features
According to NCCN Guidelines, post-RARP surveillance typically includes:
- PSA every 3-6 months for first 2 years
- PSA every 6-12 months thereafter
- Imaging only if PSA rises
Your Current Status
I notice from your medical file that you've had your surgery ([date removed]).
The most important question now is:
What is your current PSA level?
This is the key indicator of surgical success. You mentioned earlier a PSA result of 0.007 ng/mL — which would be excellent (essentially undetectable).
Can you clarify:
- When was this PSA test done? (What date after surgery?)
- Is 0.007 ng/mL your most recent result?
- Have you had any PSA results since surgery?
This will help me explain what your post-surgery PSA means for your recovery and long-term outlook.
Questions for Your Urologist Now
Since you've already had surgery, these are the important follow-up questions:
-
"What did the final pathology show from my removed prostate?" (Confirms cancer extent, margins, stage)
-
"What is my current PSA, and what does it mean?" (Most important indicator of surgical success)
-
"What is my surveillance schedule going forward?" (When to check PSA, when to see you)
-
"Based on my final pathology, do I need any additional treatment?" (Radiation, hormone therapy, etc.)
-
"What side effects should I expect, and when do they typically improve?" (Incontinence, erectile function, etc.)
Bottom Line
Your urologist's decision to proceed with RARP was based on solid clinical reasoning:
- ✅ Staging imaging confirmed localized cancer
- ✅ No evidence of spread
- ✅ Intermediate-risk disease appropriate for surgery
- ✅ You were a good surgical candidate
The surgery has been done. Now the focus shifts to:
- Confirming surgical success (PSA undetectable)
- Managing post-operative recovery
- Long-term surveillance
What I Need From You
To give you the most relevant educational information about your post-surgery status, please share:
- Your current PSA result (and the date it was checked)
- Any symptoms you're experiencing (incontinence, erectile dysfunction, etc.)
- Your final pathology report (if you have it) — this shows what was found in the removed prostate
- Your specific concerns — what would you like to understand better?
Authoritative Sources
- NCCN Prostate Cancer Guidelines — post-RARP surveillance recommendations
- American Urological Association — radical prostatectomy outcomes and follow-up
- American Cancer Society — life after prostate cancer surgery
I'm here to help you understand your post-surgery results and what comes next. What would you like to discuss?
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Related Services
Services that may help with treatment for cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I appreciate you sharing these details about your treatment journey. Let me help you understand what's happening and what questions to bring to your o
What signs of progression should I watch for
Based on NCCN Guidelines for Myeloproliferative Neoplasms, here are the key warning signs you should monitor and report to your oncologist: Blood Co
What questions should I ask my oncologist at my next appointment
I'd love to help you prepare for your appointment! To give you the most relevant questions, it would help to know a bit more about your situation: 1.
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
Thank you for the follow-up. I want to address something important that emerged from your medical profile: Your actual diagnosis is a fibroblastic/my
What are treatment options for KRAS G12A and PIK3CA mutations in colorectal cancer
I appreciate your question about these specific mutations. However, I want to first clarify something important about your medical profile: Your Situ